Kaustubh Bhardwaj (2026) “FUTURE CHALLENGES AND EMERGING SAFETY CONCERNS OF GLP-1 RECEPTOR AGONISTS, DUAL INCRETIN AGONISTS, AND SGLT2 INHIBITORS”, Journal of Population Therapeutics and Clinical Pharmacology, 33(2), pp. 963–981. doi:10.69980/mng8r305.